Baraa Abdulsalam Hraija (1)
General Background: Trichomonas vaginalis is one of the most prevalent protozoan sexually transmitted infections affecting women and is associated with reproductive and inflammatory complications. Specific Background: Accurate molecular detection and characterization of the parasite are essential for understanding its epidemiology and its interaction with host immune responses. Knowledge Gap: Despite the widespread occurrence of trichomoniasis, limited molecular and immunological data are available regarding the genetic diversity of local isolates and their relationship with inflammatory biomarkers in Iraqi populations. Aims: This study investigated the prevalence of T. vaginalis infection among women in Wasit Province, Iraq, using PCR targeting the internal transcribed spacer 1 (ITS1) region, examined the phylogenetic relationships of detected isolates, and assessed associated immune markers including cysteinyl leukotrienes, interleukin-8, and leukotriene B4. Results: Molecular analysis identified a 7.56% infection rate among 291 examined women. Sequencing and phylogenetic analysis of 22 isolates revealed strong similarity with previously reported Iraqi strains. Infected women demonstrated significantly elevated levels of CysLTs, IL-8, and LTB4 compared with non-infected individuals. Novelty: The study integrates molecular detection, phylogenetic characterization, and immunological biomarker evaluation of T. vaginalis isolates in a single population-based investigation. Implications: These findings contribute to improved epidemiological understanding of trichomoniasis and highlight the potential role of inflammatory mediators in the pathophysiology of infection.
Keywords: Trichomonas Vaginalis, ITS1 Region, Molecular Detection, Phylogenetic Analysis, Immune Biomarkers
Key Findings Highlights
PCR analysis identified trichomoniasis in 7.56% of examined women from Wasit Province.
Sequenced isolates clustered with previously reported Iraqi strains in phylogenetic analysis.
Infected participants showed marked elevation of inflammatory mediators including IL-8 and leukotrienes.
Trichomonas vaginalis is anaerobic, flagellated protozoan parasite and the causative agent of a sexually transmitted disease called trichomoniasis that infects human in industrialized countries (Mirzadeh et al., 2021). The parasite, belongs to the Trichomonadida order in the Metamonada phylum of Eukaryota domain, was first described in 1836 by Alfred Francois Donné who observed it as a motile protozoa in vaginal or cervical secretions (Gharban, 2023; Eanzi and Al-Kaabi, 2024). In 1916, Hohne declared trichomoniasis as a clinical entity with a wide range of genitourinary symptoms in affected women which could lead to more severe reproductive health complications including adverse pregnancy outcomes, and increased susceptibility to other sexually transmitted diseases including human immunodeficiency virus (HIV) disease (Van Gerwen et al., 2023; Joy et al., 2025). Although, the intricate life cycle of parasite involves several distinct stages that are crucial for its survival, proliferation, and transmission, it exists solely as a trophozoite, meaning it lacks a cyst stage and replicates by binary fission with directly contributing to its high infectivity and rapid onset of symptoms (Matti, 2022; Murkute et al., 2025).
The global prevalence of T. vaginalis in women is approximately 5.3%, yet it can be as high as 14.6% in specific cohorts, underscoring its significant epidemiological burden (Li et al., 2025). Also, the adverse clinical manifestations and the potential for asymptomatic carriage highlight the necessity of understanding the varied diagnostic approaches including microscopy, culture and nucleic acid amplification tests to effectively manage this widespread infection (Azeez et al., 2024; Shankar et al., 2025). While, wet mount microscopy remains a commonly utilized point-of-care test, its sensitivity for T. vaginalis detection is notably low often ranging from 31% to 60%, limiting its utility in identifying asymptomatic or low-parasite-burden infections (Cardoso et al., 2024). Conversely, molecular assays such as nucleic acid amplification tests, offer superior sensitivity and specificity for T. vaginalis detection, enabling more precise diagnosis and guiding targeted therapeutic interventions (Gharban, 2023; Borges et al., 2024).
In Iraq, the earliest reports of T. vaginalis were from Al-Shabandar (1979) in Baghdad, Al-Mallan and Al-Janabi (1983) in Mosul, Kadir et al. (1988) in Erbil, Al-Saeed (1995) in Dohok, and Mahdi (1995) in Basra. Then, several studies have been conducted in Iraq (AL-Marjan and Sadeq, 2022; Al-Hasnawy and Rabee, 2023; Hansh, 2024) as well as in Wasit province (Rahi et al., 2014a, b; Rahi and Jaleel, 2022a, b) to estimate the incidence rate of T. vaginalis infection; however, data concerned to genotypic diversity remain underscoring in Iraq (Merdaw et al., 2018; Al-Rubaye and Alkhashab, 2022; Nasir et al., 2022), with complete lack of such information in Wasit province. Therefore, this study identifies the prevalence rate of human trichomoniasis in women of Wasit province (Iraq) directly by molecular PCR assay through targeting ITS1, and phylogenetic analysis of study T. vaginalis isolates. Association of positivity to immune response was aimed, also.
Ethical approval
Scientific Committee in College of Medicine (University of Wasit) was licensed this study.
Samples
In total, 291 women with different socio-demographic characteristics and reproductive diseases were hospitalized with the private gynecological clinics in Wasit province (Iraq) in March-June (2025) and were picked to participate in the present study. Sampling of vaginal swabs was done on all of the study women that maintained frozen state of -20°C before being subjected to molecular examination. Additionally, 5ml of venous blood was drained from each study individual into free-anticoagulant glass-gel tube that centrifuged (5000rpm/5 min), and the obtained sera were kept into 1.5ml Eppendorf tubes and saved frozen (-20°C) until be tested serologically.
Molecular conventional PCR assaying
DNAs were purified out of the vaginal swabs after thawing in the water bath at 37° C with the g SYNCTM DNA extraction kit (Genaid, Taiwan), analyzed by the Nandrop spectrophotometer, and they were used to prepare MasterMix tubes at a final quantity of 25µl. One of the primers was specific to this study (ITS1): (IQF: 5ʹ-CCT GCC GTT GGA TCA GTT CT-3ʹ and IQR: 5ʹ-TTC CAG TTC AGC GGG TCT TC-3ʹ) using NCBI-GenBank T. vaginalis isolates (https://www.ncbi.nlm.nih.gov/nuccore/PX147461.1). Subsequent post amplification was carried out in Thermal Cycler system after modified conditions (Table 1), PCR products electrophoresis was conducted in 1.5% agarose-gel, with 90 minutes of Amperometric input of 80 Am and Voltage of 100 V and the positive samples of T. vaginalis isolates were visualized at an approximate position within the UV illuminator at 364 bp.
Sequencing and phylogeny
All the positive T. vaginalis isolates DNA were sequenced at the Macogen Company (Korea). The information was submitted to the NCBI-GenBank database with accession numbers assigned, and it was analyzed by phylogenetic software with the NCBI-Viewer (version 1.26) and MEGA software (version 11). Homology sequence identity, multiple sequence alignment, and phylogenetic tree analysis were conducted to prove the strong correlation between the study local and NCBI-BLAST T. vaginalis isolates/strains.
Immunology
According to manufacturer instructions (SunLong Biotech, China) of quantitative ELISAs’ kits, the concentrations of CysLTs (Cat. No: SL0576Hu), IL-8 (Cat. No: SL1004Hu), and LTB4 (Cat. No: SL1068Hu) were measured in the sera of study population. For each immune marker, the kit’s contents and the sera were prepared, processed, and the absorbance was read by the ELISA Reader at an optical density (OD) of 450nm. Then, the ODs and concentrations of Standards in addition to ODs of the samples were plotted on the Standard Curve to calculate the concentration of immune marker tested samples.
Statistical analysis
The t-test in GraphPad Prism software was applied to detect significant differences between the values of positively and negatively infected individuals at p<0.05 with calculation of 95% confidence interval (95%CI), (Al-Gharban, 2017).
Molecular examination of 7.56% (22/291) of study women were positively infected by T. vaginalis using the conventional PCR and targeting the ITS1 region (Figure 1). The sequence data of all the positive T. vaginalis isolates (total=22) were entered in the NCBI-GenBank database, named (IQ-BARHAS 1, IQ-BARHAS 2, IQ-BARHAS 3, IQ-BARHAS 4, IQ-BARHAS 5, IQ-BARHAS 6, IQ-BARHAS 7, IQ-BARHAS 8, IQ-BARHAS 9, IQ-BARHAS 10, IQ-BARHAS 11, IQ-BARHAS 12, IQ-BARHAS 13, IQ-BARHAS 14, IQ-BARHAS 15, IQ-BARHAS 16, IQ-BARHAS 17, IQ-BARHAS 18, IQ-BARHAS 19, IQ-BARHAS 20, IQ-BARHAS 21, and IQ-BARHAS 22) and got respectively specific access numbers (PX920213.1, PX920214.1, PX920215.1, PX920216.1, PX920217.1, PX920218.1, PX920219.1, PX920220.1, PX920221.1, PX920222.1, PX920223.1, PX920224.1, PX920225.1, PX920226.1, PX920227.1, PX920228.1, PX920229.1, PX920230.1, PX920231.1, PX920232.1, PX920233.1, and PX920234.1). Phylogenetic analysis with the NCBI-BLAST T. vaginalis isolates / strains revealed that all study T. vaginalis isolates having a similarity (*) ranged from 98.10% to 99.46% and mutation / changes ranged from 0.003-0.02% with the NCBI-BLAST T. vaginalis Iraqi strain (ID: PQ403668.1), (Table 2, Figures 2-4).
Figure 1. Figure ( 1 ): Total molecular results for testing 291 vaginal swabs by PCR assay targeting the ITS1 region for T. vaginalis
Figure 2.
Figure 3. Figure ( 2 ): MSA of study and NCBI-GenBank T. vaginalis isolates / strains targeting the ITS1 region by the MEGA software showing nucleic acids similarity and differences
Figure 4.
Figure 5. Figure ( 3 ): MSA of study and NCBI-GenBank T. vaginalis isolates / strains targeting the ITS1 region by the NCBI-Viewer software showing nucleic acids similarity and differences
Figure 6. Figure ( 4 ): Phylogenetic tree analysis of study and NCBI-GenBank T. vaginalis isolates / strains targeting the ITS1 region
The findings of immunological markers have reported a significant variation (p<0.0001) in their values among the positively (Figures 5-7). Significantly, the positively infected women were reported an elevation (95%CI: 1105 to 1456) in values of CysLTs (276.04±12.58pg/ml) compared to those of negatively infected individuals (74.48±2.77pg/ml). For IL-8, there was a significant increase (95%CI: 518.7 to 685.4) in values of positively T. vaginalis infected women (130.75±4.59pg/ml) in comparison with those of negatively result (35.98±3.48pg/ml). For LTB4, the positively infected T. vaginalis women (1496.5±70.06pg/ml) were shown the significant higher values (95%CI: 6115 to 7997) than negative values (385.93±10.92pg/ml).
Figure 7. Figure ( 5 ): Levels of serum CysLTs in positively and negatively study population to T. vaginalis
Figure 8. Figure ( 6 ): Levels of serum IL-8 in positively and negatively study population to T. vaginalis
Figure 9. Figure ( 7 ): Levels of serum LTB4 in positively and negatively study population to T. vaginalis
The findings of molecular PCR recorded that the incidence rates of human T. vaginalis in women of Wasit province were 7.56%. In comparison to other local studies, the occurrence of human trichomoniasis was 38.1% in Al-Anbar using the microscopic examination of vaginal swab (Al-Ani et al., 2001), 1.66% in Sulaimania by direct microscopic examination and culture (Fattah and Kadir, 2010), 5.23% in Thi-Qar by wet method (Al-Abady and Al-Khazrajee, 2014), 8.33-21.67 % in Wasit by wet mount microscopy, Whif test, and RT-PCR (Rahi et al., 2014a,b), 12.41% in Diyala by wet mount examination (Hussein and Shaker, 2017), 62% in Tikrit by direct wet mount and liquid cultivate (Al-Ammash, 2017), 27.90% in Al-Najaf by wet mount examination (Al-Abbas and Radhi, 2019), 26-32% in Al-Muthana by wet smear and PCR (Al-Abodi et al., 2019), 2.73-3.18% in Erbil by direct wet method and culture respectively (Nouraddin and Alsakee, 2019), 28.10% in Kirkuk by microscopic examination of endocervical and vaginal swabs as well as urine (Salman et al., 2019), 26.27% in Babylon by wet mount (Al-Kahfaji and Seher, 2020), 75.22% in Maysan by microscopic examination and cultivation (Al-Majidii and Alsaady, 2020), 25.5% and 29.5% in Al-Qadisiyah by wet smear and RT-PCR, respectively (AL-Khalidy and Al-abodi, 2020), 8.7-40.35% by microscopic examination of vaginal swabs and urine as well as indirect ELISA (Bedair and Ali, 2020), 0.5-1.6% in Basra by direct microscopic examination of vaginal swabs and urine (Kadhum et al., 2020), 5.5-8.62% in Karbala by wet mount, gram staining and PCR (Alhusseini and Alquraishi, 2021), 3.3% in Mosul by wet mount (AL-TAEI, 2022), 5.5% in Baghdad by PCR (Ghaima, 2022), and 9% in Duhok by microscopically wet mount examination (Murad et al., 2024). However, variations between the findings of the current study and the above mentioned studies could be attributed differences in diagnostic methods, study population (socio-demographic factors), geographical location, screening practices, sample size and type, and the presence of various T. vaginalis strains or other bacterial or viral infections that could interfere with the examination and interpretation of results.
Phylogenetically, high genetic identity was shown between the current study T. vaginalis isolates and the NCBI-BLAST Iraqi T. vaginalis strain that isolated from endocervix of non-married and married women in Duhok province suggesting that this strain might be circulated in Iraqi population women, and its responsible for infections across different locations in Iraq. However, ITS1 region that situated between the 18S rRNA and 5.8S rRNA genes is offered substantial variability that facilitates the taxonomic identification and subtyping of closely related protozoan parasites (Choudhary et al., 2015; Somasundaram and Yu, 2025). This genetic locus is present in multiple copies within the genome, which enhances the sensitivity of PCR amplification compared to single-copy targets (Ellingham et al., 2019). Consequently, this multi-copy nature not only increases diagnostic sensitivity but also provides sufficient sequence divergence to discriminate between distinct strains and subspecies during phylogenetic characterization (Mochizuki et al., 2017; Jarquín-Díaz, 2021).
In comparison with the negatively infected T. vaginalis population, the positively infected women were reported a significant elevation in values of studied immune markers including CysLTs, IL-8, and LTB4. These results in agreement with observed by many researchers (Nam et al., 2012; Lee and Shin, 2024; Farhan, 2025). Nonetheless, the precise mechanisms by which T. vaginalis influences the synthesis and modulation of CysLTs remain an active area of investigation, but it is hypothesized that parasitic factors directly or indirectly trigger host inflammatory cascades that likely involving the activation of specific immune cells and releasing of various pro-inflammatory mediators, and subsequently affect the arachidonic acid pathway to produce leukotrienes (Jafarzadeh et al., 2023; Kou et al., 2024; Zhang and He, 2024). This intricate interplay between the parasite and host immune response could lead to an up-regulation of enzymes involved in leukotriene synthesis thereby contributing to the inflammatory pathogenesis observed in trichomoniasis (Rashidi et al., 2022). Also, T. vaginalis can induce the production of IL-8, a potent chemokine that attracts neutrophils and other immune cells to the site of infection, contributing to the inflammatory response and potentially exacerbating tissue damage (Bhakta et al., 2020; Zhang and He, 2024). This sustained pro-inflammatory cytokine secretion can contribute to chronic cervicitis and create a microenvironment conducive to persistence and progression of infections thereby increasing the risk of cervical intraepithelial neoplasia (Gargiulo Isacco et al., 2023). Moreover, this chronic inflammatory state and altered immune cell recruitment, partly mediated by IL-8, can promote genomic instability and activate oncogenic pathways, facilitating viral integration and subsequently leading to infertility due to damaging of reproductive tissues and impairment of normal physiological processes (Jarrett et al., 2015; Avitabile et al., 2024). LTB4, a potent lipid mediator derived from arachidonic acid metabolism, is implicated also in the inflammatory response orchestrated by T. vaginalis (Maddipati et al., 2016; Cheng et al., 2025). This chemotactic agent contributes to the recruitment of neutrophils and the perpetuation of localized inflammation within the cervicovaginal epithelium to further exacerbating tissue damage and modulating the immune response (Bhakta et al., 2020; Obeagu, 2024).
This study indicates that rapid test and/or molecular PCR can provide important data about the prevalence of T. vaginals in Iraqi population of various socio-demographic aspects who appeared with or without clinical symptoms. Phylogenetically, the local T. vaginalis isolates were markedly identical to another local T. vaginals strain indicating the importance of this strain and the possible its role in women infections. Also, targeting of ITS1 region offered a high sensitivity and specificity in molecular detection of infection and phylogenetic detection of local isolates. Therefore, additional molecular sequencing data based on ITS1 regions appears greatly necessary as such data can be utilized in epidemiology of parasitic infection. Serological elevation of immune markers in positively infected women might further complicates the pathological landscape and enhance the inflammatory cascade with promoting the proliferation of pathogenic bacteria.
Conflict of interests
Author declares no conflict of interest.
Al-Abady, F. A., and Z. A. Al-Khazrajee, “Epidemiology Study Parasite *Trichomonas vaginalis* at Thi-Qar Province,” *Journal of Thi-Qar University*, vol. 9, no. 1, pp. 1–9, 2014.
Al-Abbas, W. D. S., and O. A. Radhi, “Incidence of *Chlamydia trachomatis* and *Trichomonas vaginalis* Genital Infections Among Nonpregnant Women in Al-Najaf Province,” *Kufa Journal for Nursing Sciences*, vol. 9, no. 1, pp. 1–8, 2019.
Al-Abodi, H. R. J., K. T. M. Al-Shaibani, and E. M. Shaker, “Molecular Investigation of Trichomoniasis in Women in Al-Muthana Province, Iraq,” *Journal of Physics: Conference Series*, vol. 1234, no. 1, p. 012078, 2019.
Al-Ammash, M. S. J., “Study on Prevalence of *Trichomonas vaginalis* in Samarra City with Observation of Alcoholic Extract Effect of *Peganum harmala* Plant in Vitro,” *Tikrit Journal of Pharmaceutical Sciences*, vol. 12, no. 1, pp. 31–47, 2017.
Al-Ani, S. F. I. H., I. A. W. Al-Hadithi, and R. J. K. Al-Hadithi, “Factors Affecting Vaginal Trichomoniasis Among Women in Ramadi,” *Basrah Journal of Research*, vol. 27, pp. 24–35, 2001.
Al-Gharban, H. A. A. J., “Seroepidemiological Detection and Culture Utilization for Diagnosis of Carrier Horses and Donkeys with Strangles,” *Journal of Education College Wasit University*, vol. 1, no. 28, pp. 649–660, 2017.
Al-Hasnawy, M. H., and A. H. Rabee, “A Review on *Trichomonas* Species Infection in Humans and Animals in Iraq,” *Iraqi Journal of Veterinary Sciences*, vol. 37, no. 2, pp. 305–313, 2023.
Alhusseini, Z. A., and M. A. Alquraishi, “Epidemiological Study and Detection of *Trichomonas vaginalis* Parasite in Holy Karbala Governorate,” *Teikyo Medical Journal*, vol. 44, no. 6, pp. 3297–3305, 2021.
Al-Kahfaji, A., and M. Seher, “Infection Rate of Trichomoniasis Among Women in Al Hilla City,” *Indian Journal of Public Health Research and Development*, vol. 11, no. 2, p. 2364, 2020.
Al-Khalidy, K. A., and H. R. Al-Abodi, “Effect of Vaginal Trichomoniasis on Women Who Suffer from Delayed Pregnancy,” *European Journal of Molecular and Clinical Medicine*, vol. 7, no. 1, pp. 44–49, 2020.
Al-Majidii, N. K. S., and H. A. M. Alsaady, “The Prevalence of *Trichomonas vaginalis* Parasite Among Women in Some Regions of Maysan Province,” *Periodico Tche Quimica*, vol. 17, no. 36, pp. 784–797, 2020.
Al-Mallan, O., and B. M. Al-Janabi, “The Incidence of *Trichomonas vaginalis* Among Selected Groups of Women in Mosul,” *Iraqi Medical Journal*, vol. 31, pp. 29–33, 1983.
Al-Marjan, K. S., and T. W. Sadeq, “A Systematic Review of *Trichomonas vaginalis* in Iraq,” *Pharmacy and Applied Health Science Journal*, vol. 1, no. 1, pp. 1–5, 2022.
Al-Rubaye, F. S., and F. Alkhashab, “Genotypes Diversity and Virulence Factor Screening of *Trichomonas vaginalis* Isolated from Pregnant Women in Mosul, North of Iraq,” *Baghdad Science Journal*, vol. 19, no. 5, p. 5, 2022.
Al-Saeed, W. M., “Detection of *Trichomonas vaginalis* by Different Methods in Women from Dohok Province, Iraq,” *Eastern Mediterranean Health Journal*, vol. 17, no. 9, 1995.
Al-Shabandar, N., *Histopathological Studies on Trichomonas*. Baghdad, Iraq: University of Baghdad, MSc Thesis, 1979.
Al-Taei, K. A., “Detection of *Trichomonas vaginalis* in Women with Vaginitis in Mosul City,” *International Journal of Applied Science and Technology*, vol. 4, no. 3, pp. 428–440, 2022.
Avitabile, E., L. Menotti, V. Croatti, B. Giordani, C. Parolin, and B. Vitali, “Protective Mechanisms of Vaginal Lactobacilli Against Sexually Transmitted Viral Infections,” *International Journal of Molecular Sciences*, vol. 25, no. 17, p. 9168, 2024.
Azeez, Z. F., Z. H. A. Al-Saadi, and Q. K. M. Almasood, “Diagnostic Approaches for Sexually Transmitted Infections in Clinical Microbiology: A Comprehensive Review,” *International Journal of Medical Science and Dental Health*, vol. 10, no. 2, pp. 1–16, 2024.
Bedair, N. H., and H. Z. Ali, “Comparison of Trichomoniasis Diagnosis by Microscopic Methods and Indirect ELISA Technique in a Sample of Iraqi Women,” *Iraqi Journal of Science*, pp. 742–748, 2020.
Bhakta, S. B., J. A. Moran, and F. Mercer, “Neutrophil Interactions with the Sexually Transmitted Parasite *Trichomonas vaginalis*: Implications for Immunity and Pathogenesis,” *Open Biology*, vol. 10, no. 9, p. 200192, 2020.
Borges, A. V. B. E., H. F. Perini, E. A. Alvin, A. C. A. Silva, and M. V. da Silva, “Point-of-Care Assays to *Trichomonas vaginalis* Diagnosis: The Road So Far,” *Venereology*, vol. 3, no. 3, pp. 107–119, 2024.
Cardoso, F. G., M. D. Freitas, T. Tasca, and G. V. Rigo, “From Wet Mount to Nucleic Acid Amplification Techniques: Current Diagnostic Methods and Future Perspectives for *Trichomonas vaginalis* Detection,” *Venereology*, vol. 3, no. 1, pp. 35–50, 2024.
Choudhary, K., A. K. Verma, S. Swaroop, and N. Agrawal, “A Review on the Molecular Characterization of Digenean Parasites Using Molecular Markers with Special Reference to ITS Region,” *Helminthologia*, vol. 52, no. 3, p. 167, 2015.
Cheng, W. H., R. M. Chen, S. C. Ong, Y. M. Yeh, P. J. Huang, and C. C. Lee, “Interaction of Human Neutrophils with *Trichomonas vaginalis* Protozoan Highlights Lactoferrin Secretion,” *Journal of Microbiology, Immunology and Infection*, vol. 58, no. 1, pp. 138–147, 2025.
Eanzi, R. M. J., and N. A. M. Al-Kaabi, “Molecular Detection of *Trichomonas vaginalis* from Women in Babylon Province, Iraq,” *Regulatory Mechanisms in Biosystems*, vol. 15, no. 4, pp. 976–979, 2024.
Ellingham, O., J. David, and A. Culham, “Enhancing Identification Accuracy for Powdery Mildews Using Previously Underexploited DNA Loci,” *Mycologia*, vol. 111, no. 5, pp. 798–812, 2019.
Farhan, A. D., “Estimation of Serum Leukotriene and Some Interleukin Levels in Women Infected with *Trichomonas vaginalis* Parasite,” *Academic Science Journal*, vol. 3, no. 3, pp. 188–199, 2025.
Fattah, C. O., and M. A. Kadir, “*Trichomonas vaginalis* Among Women in Sulaimania Governorate, Iraq,” *Tikrit Journal of Pharmaceutical Sciences*, vol. 6, no. 1, pp. 1–9, 2010.
Gargiulo Isacco, C., M. G. Balzanelli, S. Garzone, M. Lorusso, F. Inchingolo, K. C. Nguyen, and R. Del Prete, “Alterations of Vaginal Microbiota and *Chlamydia trachomatis* as Crucial Co-Causative Factors in Cervical Cancer Genesis Procured by HPV,” *Microorganisms*, vol. 11, no. 3, p. 662, 2023.
Ghaima, R. B. A. K. K., “Molecular Detection of Some Sexually Transmitted Bacteria and *Trichomonas vaginalis* in Iraqi Married Couples,” *Iraqi Journal of Biotechnology*, vol. 21, no. 2, pp. 136–142, 2022.
Gharban, H. A., “Molecular Prevalence and Phylogenetic Confirmation of Bovine Trichomoniasis in Aborted Cows in Iraq,” *Veterinary World*, vol. 16, no. 3, pp. 580–587, 2023.
Hansh, W. J., “A Review on *Trichomonas vaginalis* and the Role of Demographic Variables in the Prevalence in Iraq,” *Maaen Journal for Medical Sciences*, vol. 3, no. 1, pp. 76–84, 2024.
Hussein, A. A., and M. J. Shaker, “Infection Rate of *Trichomonas vaginalis* Among Women in Baqubah City,” *International Journal of Scientific Research*, vol. 6, no. 8, pp. 1954–1957, 2017.
Jafarzadeh, A., M. Nemati, E. Salarkia, S. Yadav, N. Aminizadeh, S. Jafarzadeh, and M. Yadav, “Inflammatory Responses During Trichomoniasis: The Role of Toll-Like Receptors and Inflammasomes,” *Parasite Immunology*, vol. 45, no. 8, p. e13000, 2023.
Jarquín-Díaz, V. H., *Integrative Analysis of Morphology, Multi-Locus Genotyping and Host Usage: A Case Study in* Eimeria *Species*, Berlin, Germany: Humboldt University of Berlin, 2021.
Jarrett, O. D., K. E. Brady, S. P. Modur, J. Plants, A. L. Landay, M. Ghassemi, and R. M. Novak, “*Trichomonas vaginalis* Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN,” *PLOS ONE*, vol. 10, no. 6, p. e0130146, 2015.
Joy, L., A. Bhalerao, S. Mulchandani, and A. Jain, “*Trichomonas vaginalis* and Female Reproductive Health,” in *Trichomonas vaginalis*, Academic Press, 2025, pp. 93–110.
Kadhum, N. J., S. H. Al-Mayah, and S. J. Raisan, “Epidemiological Study on *Trichomonas vaginalis* Among Women Attending Hospitals in Basra Province,” *Journal of Basrah Researches (Sciences)*, vol. 46, no. 2, 2020.
Kadir, M. A., A. M. S. Salehy, and E. F. Hammad, “Studies on *Trichomonas vaginalis* in Erbil Teaching Hospital,” *Journal of the Faculty of Medicine Baghdad*, vol. 30, pp. 83–88, 1988.
Kou, Y., S. Zhang, J. Chen, Y. Shen, Z. Zhang, H. Huang, and Y. Wang, “A Mouse Protozoan Boosts Antigen-Specific Mucosal IgA Responses in a Lipid Metabolism and Signaling Dependent Manner,” *Nature Communications*, vol. 15, no. 1, p. 7914, 2024.
Lee, Y. A., and M. H. Shin, “CysLT Receptor-Mediated NOX2 Activation Is Required for IL-8 Production in HMC-1 Cells Induced by *Trichomonas vaginalis* Secretory Products,” *Parasites, Hosts and Diseases*, vol. 62, no. 3, p. 270, 2024.
Li, S., J. Xu, S. Ru, C. Hu, C. Liu, X. Sun, and X. Zhang, “Prevalence of *Trichomonas vaginalis* Among Women in the Chinese Population: A Systematic Review and Meta-Analysis,” *Tropical Medicine and Infectious Disease*, vol. 10, no. 4, p. 113, 2025.
Maddipati, K. R., R. Romero, T. Chaiworapongsa, P. Chaemsaithong, S. L. Zhou, Z. Xu, and K. V. Honn, “Lipidomic Analysis of Patients with Microbial Invasion of the Amniotic Cavity Reveals Up-Regulation of Leukotriene B4,” *The FASEB Journal*, vol. 30, no. 10, p. 3296, 2016.
Mahdi, N. K., “Urogenital Trichomoniasis in an Iraqi Population,” *Eastern Mediterranean Health Journal*, vol. 2, no. 3, pp. 1–5, 1995.
Matti, M., *An Effort to Elucidate Mechanisms of the RNA Interference Pathway in* Trichomonas vaginalis. Auckland, New Zealand: University of Auckland, Doctoral Dissertation, 2022.
Merdaw, M. A. Z., H. S. Kadhim, F. Abd Alsattar Alriyahee, N. M. T. Al-Bashier, and L. H. Al-Taie, “Genetic Variation of *Trichomonas vaginalis* Isolates from Iraqi Women: Association with Fertility and Cervical Abnormalities,” *Journal of University of Babylon for Pure and Applied Sciences*, vol. 26, no. 7, pp. 321–338, 2018.
Mirzadeh, M., M. Olfatifar, A. V. Eslahi, A. Abdoli, E. Houshmand, H. Majidiani, and M. Badri, “Global Prevalence of *Trichomonas vaginalis* Among Female Sex Workers: A Systematic Review and Meta-Analysis,” *Parasitology Research*, vol. 120, no. 7, pp. 2311–2322, 2021.
Mochizuki, T., K. Takeda, and K. Anzawa, “Molecular Markers Useful for Intraspecies Subtyping and Strain Differentiation of Dermatophytes,” *Mycopathologia*, vol. 182, no. 1, pp. 57–65, 2017.
Murad, M. A., S. A. Ibrahim, and A. Y. Mahmood, “Distribution and Risk Factors of *Trichomonas vaginalis* Infection with Relevance to Interleukin Profile Among Population in Duhok City, Iraq,” *Clinical Epidemiology and Global Health*, vol. 30, p. 101784, 2024.
Murkute, S. D., P. B. Patil, D. S. Chaudhari, and N. P. Patil, “Structure, Morphology, and Global Epidemiology of *Trichomonas vaginalis*,” in *Trichomonas vaginalis*, Academic Press, 2025, pp. 13–38.
Nam, Y. H., A. Min, S. H. Kim, Y. A. Lee, K. A. Kim, K. J. Song, and M. H. Shin, “Leukotriene B4 Receptors BLT1 and BLT2 Are Involved in Interleukin-8 Production in Human Neutrophils Induced by *Trichomonas vaginalis* Secretory Products,” *Inflammation Research*, vol. 61, no. 2, pp. 97–102, 2012.
Nasir, M. A., S. R. Al-Idreesi, and W. A. Al-Masoudi, “Investigation of Trichomoniasis Among Women from Basra Province, Iraq Using the PCR Technique,” *International Journal of Scientific and Engineering Research*, vol. 13, no. 12, pp. 521–530, 2022.
Nouraddin, A. S., and H. M. Alsakee, “Immunological Aspects of *Trichomonas vaginalis* Infection in Women Attending Maternity Teaching Hospital and Public Health Centers in Erbil Governorate,” *Cihan University-Erbil Scientific Journal*, vol. 3, no. 1, pp. 56–60, 2019.
Obeagu, E. I., “From Inflammation to Invasion: Neutrophils in Cervical Cancer Pathogenesis,” *Annals of Medicine and Surgery*, 2024.
Rahi, A. A., M. A. Ali, and A. Khamesipour, “Comparison of Real-Time PCR with Traditional Tools for Diagnosis of *Trichomonas vaginalis* in Patients with Vaginal Discharge at Kut City, Iraq,” *Journal of Advances in Biology*, vol. 5, no. 3, 2014.
Rahi, A. A., R. W. Kadhim, and H. Sajad, “Prospective Study of *Trichomonas vaginalis* Infection,” *Scholars Journal of Applied Medical Sciences*, vol. 2, no. 1D, pp. 455–460, 2014.
Rahi, A. A., and I. A. Jaleel, “A Study of *Trichomonas vaginalis* Infection Among Women in Wasit Province, Iraq,” *International Journal of Health Sciences*, vol. 6, suppl. 8, pp. 3484–3489, 2022.
Rahi, A. A., and I. A. Jaleel, “Feasibility of Nested PCR for Diagnosis of *Trichomonas vaginalis* Infection in Women in Wasit Province, Iraq,” *International Journal of Health Sciences*, vol. 6, suppl. 8, pp. 3490–3499, 2022.
Rashidi, S., R. Mansouri, M. Ali-Hassanzadeh, A. Muro, P. Nguewa, and R. Manzano-Román, “Defensive Interactions of Prominent Infectious Protozoan Parasites with the Host Complement System,” *Biomolecules*, vol. 12, no. 11, p. 1564, 2022.
Salih, B. A., H. M. Obaid, and N. A. Al-Kadi, “Assessment of Changes in Hormonal Levels in Women Infected with *Trichomonas vaginalis* in Kirkuk, Iraq,” *Medical Journal of Babylon*, vol. 20, suppl. 1, pp. S180–S184, 2023.
Salman, Y. J., E. S. Ahmed, and R. H. Taqi, “ABO Blood Group and Incidence of *Chlamydia trachomatis* and *Trichomonas vaginalis* Infections Among Childbearing Women in Kirkuk Province,” *Journal of Medical Science and Clinical Research*, vol. 7, no. 4, pp. 1106–1116, 2019.
Shankar, P., S. Pandey, A. Shrivas, S. Gupta, M. K. Sharma, D. Parashar, and P. Khare, “Recent Advances in the Diagnosis of *Trichomonas vaginalis* Infections,” Elsevier, pp. 197–223, 2025.
Somasundaram, S., and Z. Yu, “Internal Transcribed Spacers Enable Species-Level Metataxonomic Analysis of Ciliated Protozoa,” *ISME Communications*, vol. 5, no. 1, pp. 1–13, 2025.
Van Gerwen, O. T., S. A. Opsteen, K. J. Graves, and C. A. Muzny, “Trichomoniasis,” *Infectious Disease Clinics of North America*, vol. 37, no. 2, p. 245, 2023.
Zhang, Y., and Z. He, “Inflammatory Mediators in Bacterial Vaginosis: The Role of Cytokines,” *APMIS*, vol. 132, no. 4, pp. 245–255, 2024.